NF1 deficiency drives metabolic reprogramming in ER+ breast cancerRachel J. House(Van Andel Institute), Matthew R. Steensma(Spectrum Health)Molecular MetabolismJanuary 10, 202410.1016/j.molmet.2024.101876Cited by 13SaveCiteExport RISWatch citationsRelated PapersDown Regulation of Wnt Signaling Mitigates Hypoxia-Induced Chemoresistance in Human Osteosarcoma Cells|PLoS ONE|2014|41Targeting the Giant Cell Tumor Stromal Cell: Functional Characterization and a Novel Therapeutic Strategy|PLoS ONE|2013|34Anoikis-resistant subpopulations of human osteosarcoma display significant chemoresistance and are sensitive to targeted epigenetic therapies predicted by expression profiling|Journal of Translational Medicine|2015|30